Celldex Therapeutics, Inc. — Institutional Ownership

Which tracked institutions hold CLDX, and how they changed the position last quarter. Latest holdings as of Mar 31, 2026. Source: SEC 13-F filings.

21
Funds holding
$353351261
Total value held
Buying
14 added/new · 7 reduced
# Institution Value Shares Δ Shares Change (QoQ)
1 Blackrock, Inc. $170332752 5369885 -81930 -1.50%
2 State Street Corp $88948209 2804168 -593545 -17.47%
3 Goldman Sachs Group Inc $31352555 988416 -79715 -7.46%
4 Bank Of America Corp /De/ $22478282 708647 +293759 +70.80%
5 Northern Trust Corp $18310909 577267 +27269 +4.96%
6 Morgan Stanley $6900673 217549 -67986 -23.81%
7 Bank Of New York Mellon Corp $6039458 190399 -4153 -2.13%
8 Wells Fargo & Company/Mn $2487829 91599 +23843 +35.19%
9 Invesco Ltd. $2448311 90144 +11258 +14.27%
10 Sei Investments Co $1210186 38152 NEW BUY
11 Janus Henderson Group Plc $813621 25642 NEW BUY
12 Barclays Plc $443288 13975 NEW BUY
13 Bank Of Montreal /Can/ $412201 12995 NEW BUY
14 Citigroup Inc $405281 14922 -7472 -33.37%
15 Marex Group Plc $380640 12000 NEW BUY
16 Prudential Financial Inc $329983 10403 NEW BUY
17 Us Bancorp \De\ $24488 772 +50 +6.93%
18 Royal Bank Of Canada $16000 502 NEW BUY
19 Pnc Financial Services Group, Inc. $15385 485 -50 -9.35%
20 Fifth Third Bancorp $969 31 NEW BUY
21 Amalgamated Financial Corp. $241 7080 NEW BUY

Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.